It has also been shown that indisulam and other reagents can target RBM39, a major component of a protein complex that is upregulated in AML and required for correct splicing of several pre-mRNAs required for AML cell survival with relatively little effect on normal cells [87]. The gene discussed is RBM39; the disease is acute myeloid leukemia.